Profile of continuous medical treatment in oncologic patient
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/15481 |
Resumo: | Goal: Describe the profile of continuous medical treatment in oncologic patient assisted in a CACON. Method: A Cross-sectional study, analytical and quantitative. The sample is constituted by patients diagnosed with cancer, inserted to begin oncologic treatment at the High Complexity Center (CACON), evaluated in the period of August, 2018 and January, 2019. Results: Two hundred seventy patients participated in the research, fifty- three percent were of female gender and fifty-one point one percent over sixty years old. It was found asssociation between the use of the medicament and: female sex (p=0.025); be married or have a companion (p=0.049); and over sixty years old (p=0.000). The most used medicament group by oncologic patients in treatment with continuous medicine was the cardiovascular system (69.56%). It was verified the association between using continuous medicine and self-reporting of: hypertension (p=0.000); diabetes mellitus (p=0.013); acute myocardial infarction (p=0.045); depression (p=0.001) and alcoholic drinks (p=0.000). Conclusion: It is important to know the treatment profile of the continuous medicine users in oncologic treatment to ensure the patients safety and the effectiveness of the treatment. |
id |
UNIFEI_70824e4a3006932e97bd4f8f860058a4 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/15481 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Profile of continuous medical treatment in oncologic patientPerfil del tratamiento farmacológico continuo en pacientes oncológicosPerfil de tratamento com medicamentos contínuos em pacientes oncológicosMedicamentosCâncerDoenças crônicasPaciente.Medicamentos CáncerEnfermedades crónicasPaciente.Medicine CancerChronic diseasePatient.Goal: Describe the profile of continuous medical treatment in oncologic patient assisted in a CACON. Method: A Cross-sectional study, analytical and quantitative. The sample is constituted by patients diagnosed with cancer, inserted to begin oncologic treatment at the High Complexity Center (CACON), evaluated in the period of August, 2018 and January, 2019. Results: Two hundred seventy patients participated in the research, fifty- three percent were of female gender and fifty-one point one percent over sixty years old. It was found asssociation between the use of the medicament and: female sex (p=0.025); be married or have a companion (p=0.049); and over sixty years old (p=0.000). The most used medicament group by oncologic patients in treatment with continuous medicine was the cardiovascular system (69.56%). It was verified the association between using continuous medicine and self-reporting of: hypertension (p=0.000); diabetes mellitus (p=0.013); acute myocardial infarction (p=0.045); depression (p=0.001) and alcoholic drinks (p=0.000). Conclusion: It is important to know the treatment profile of the continuous medicine users in oncologic treatment to ensure the patients safety and the effectiveness of the treatment.Objetivo: Describir el perfil de los pacientes oncológicos, al inicio del tratamiento, con medicación continua, asistidos en un CACON. Método: Se trata de un estudio transversal, cuantitativo y analítico. La muestra estuvo constituida por pacientes diagnosticados de cáncer insertados para iniciar tratamiento oncológico en el Centro de Alta Complejidad (CACON), evaluados entre agosto de 2018 y enero de 2019. Resultados: participaron en la investigación 270 pacientes, 53% de ellos mujeres y 58,1% mayores de 60 años de edad. Hubo asociación entre el uso de medicamentos y: sexo femenino (p = 0.025); estar casado o tener pareja (p = 0,049); y tener más de 60 años (p = 0,000). El grupo de fármacos más utilizado por los pacientes oncológicos sometidos a medicación continua fue el sistema cardiovascular (69,56%). Se encontró una asociación entre el uso de medicación continua y el autoinforme de: hipertensión (p = 0,000); diabetes mellitus (p = 0,013); infarto agudo de miocardio (p = 0,045); depresión (p = 0,001) y consumo de bebidas alcohólicas (p = 0,000). Conclusión: El estudio permitió conocer el perfil de uso de fármacos continuos y las variables asociadas, estos datos son fundamentales para proponer medidas que mejoren la efectividad y seguridad de la quimioterapia y otros fármacos asociados.Objetivo: Descrever o perfil de pacientes oncológicos, no início do tratamento, em uso de medicamentos contínuos, assistidos em um CACON. Método: Trata-se de um estudo transversal, quantitativo e analítico. A amostra constituiu-se por pacientes com diagnóstico de câncer inseridos para iniciar o tratamento oncológico junto ao Centro de Alta Complexidade (CACON), avaliados no período de agosto de 2018 a janeiro de 2019. Resultados: Participaram da pesquisa 270 pacientes, 53% do sexo feminino e 58,1% com mais de 60 anos de idade. Verificou-se associação entre uso de medicamentos e: sexo feminino (p=0,025); ser casado ou ter acompanhante (p=0,049); e possuir mais de 60 anos (p=0,000). O grupo de medicamentos mais utilizado pelos pacientes oncológicos em tratamento com medicamentos contínuos foi do aparelho cardiovascular (69,56%). Verificada associação entre usar medicamentos contínuos e autorrelato de: hipertensão (p=0,000); diabetes mellitus (p=0,013); infarto agudo do miocárdio (p=0,045); depressão (p=0,001) e uso de bebidas alcóolicas (p=0,000). Conclusão: O estudo permitiu conhecer o perfil de uso de medicamentos contínuos e as variáveis associadas, estes dados são fundamentais para propor medidas que melhorem a efetividade e segurança da quimioterapia e dos demais medicamentos associados.Research, Society and Development2021-05-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/1548110.33448/rsd-v10i6.15481Research, Society and Development; Vol. 10 No. 6; e34010615481Research, Society and Development; Vol. 10 Núm. 6; e34010615481Research, Society and Development; v. 10 n. 6; e340106154812525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/15481/14153Copyright (c) 2021 Camile Lorenz; Sandra Drews Montagner; Eniva Miladi Fernandes Stumm; Jose Antônio Gonsales da Silva; Lenara Schalanski Krause; Juliana Maria Fachinetto ; Christiane Colethttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessLorenz, Camile Montagner, Sandra DrewsStumm, Eniva Miladi Fernandes Silva, Jose Antônio Gonsales daKrause, Lenara Schalanski Fachinetto , Juliana Maria Colet, Christiane2021-06-10T22:51:46Zoai:ojs.pkp.sfu.ca:article/15481Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:36:17.776273Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Profile of continuous medical treatment in oncologic patient Perfil del tratamiento farmacológico continuo en pacientes oncológicos Perfil de tratamento com medicamentos contínuos em pacientes oncológicos |
title |
Profile of continuous medical treatment in oncologic patient |
spellingShingle |
Profile of continuous medical treatment in oncologic patient Lorenz, Camile Medicamentos Câncer Doenças crônicas Paciente. Medicamentos Cáncer Enfermedades crónicas Paciente. Medicine Cancer Chronic disease Patient. |
title_short |
Profile of continuous medical treatment in oncologic patient |
title_full |
Profile of continuous medical treatment in oncologic patient |
title_fullStr |
Profile of continuous medical treatment in oncologic patient |
title_full_unstemmed |
Profile of continuous medical treatment in oncologic patient |
title_sort |
Profile of continuous medical treatment in oncologic patient |
author |
Lorenz, Camile |
author_facet |
Lorenz, Camile Montagner, Sandra Drews Stumm, Eniva Miladi Fernandes Silva, Jose Antônio Gonsales da Krause, Lenara Schalanski Fachinetto , Juliana Maria Colet, Christiane |
author_role |
author |
author2 |
Montagner, Sandra Drews Stumm, Eniva Miladi Fernandes Silva, Jose Antônio Gonsales da Krause, Lenara Schalanski Fachinetto , Juliana Maria Colet, Christiane |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Lorenz, Camile Montagner, Sandra Drews Stumm, Eniva Miladi Fernandes Silva, Jose Antônio Gonsales da Krause, Lenara Schalanski Fachinetto , Juliana Maria Colet, Christiane |
dc.subject.por.fl_str_mv |
Medicamentos Câncer Doenças crônicas Paciente. Medicamentos Cáncer Enfermedades crónicas Paciente. Medicine Cancer Chronic disease Patient. |
topic |
Medicamentos Câncer Doenças crônicas Paciente. Medicamentos Cáncer Enfermedades crónicas Paciente. Medicine Cancer Chronic disease Patient. |
description |
Goal: Describe the profile of continuous medical treatment in oncologic patient assisted in a CACON. Method: A Cross-sectional study, analytical and quantitative. The sample is constituted by patients diagnosed with cancer, inserted to begin oncologic treatment at the High Complexity Center (CACON), evaluated in the period of August, 2018 and January, 2019. Results: Two hundred seventy patients participated in the research, fifty- three percent were of female gender and fifty-one point one percent over sixty years old. It was found asssociation between the use of the medicament and: female sex (p=0.025); be married or have a companion (p=0.049); and over sixty years old (p=0.000). The most used medicament group by oncologic patients in treatment with continuous medicine was the cardiovascular system (69.56%). It was verified the association between using continuous medicine and self-reporting of: hypertension (p=0.000); diabetes mellitus (p=0.013); acute myocardial infarction (p=0.045); depression (p=0.001) and alcoholic drinks (p=0.000). Conclusion: It is important to know the treatment profile of the continuous medicine users in oncologic treatment to ensure the patients safety and the effectiveness of the treatment. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-05-31 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/15481 10.33448/rsd-v10i6.15481 |
url |
https://rsdjournal.org/index.php/rsd/article/view/15481 |
identifier_str_mv |
10.33448/rsd-v10i6.15481 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/15481/14153 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 10 No. 6; e34010615481 Research, Society and Development; Vol. 10 Núm. 6; e34010615481 Research, Society and Development; v. 10 n. 6; e34010615481 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052832992460800 |